GlassScriptPhysician profile
Amartyadeb Goswami
NPI 1851314728
$5,142.93
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,357 · 2020: $279 · 2021: $667 · 2022: $283 · 2023: $302 · 2024: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $556.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $1,476.90 | 2019-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Boston Scientific Corporation | $1,231.85 | 2019-2023 | Watchman Access System |
| Ucb, INC. | $430.98 | 2019-2024 | Briviact, Rystiggo |
| Sunovion Pharmaceuticals INC. | $324.90 | 2019-2022 | |
| Sk Life Science, INC. | $283.84 | 2020-2022 | |
| Abbvie INC. | $235.25 | 2021-2024 | |
| Biohaven Pharmaceuticals, INC. | $202.63 | 2021 | |
| Portola Pharmaceuticals, LLC | $158.10 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $154.64 | 2022-2023 | Andexxa |
| Jazz Pharmaceuticals INC. | $142.77 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.17 | 2019 | |
| Alexion Pharmaceuticals, INC. | $98.52 | 2019-2024 | Ultomiris |
| Amgen INC. | $83.33 | 2021 | |
| Allergan, INC. | $56.43 | 2019-2020 | |
| Eisai INC. | $56.14 | 2021-2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $39.92 | 2019 | |
| Pfizer INC. | $36.20 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $15.50 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $13.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amartyadeb Goswami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.